NCT06419517

Pelvic Muscle Training and Electrostimulation to Treat Weak Pelvic Floor

Name: Clinical Trial NCT06419517
Creator: Azienda Unità Sanitaria Locale di Piacenza
Keywords: Pelvic Floor Muscle Weakness,Incontinence Stress,Electricity; Effects,Muscle Weakness Condition, EMG-triggered ES, device, clinical trial, Italy

Efficacy of PFMT and sEMG-triggered Electrostimulation in Treating the Very Weak Pelvic Floor: a Randomized Clinical Trial

Azienda Unità Sanitaria Locale di Piacenza·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Pelvic Floor Muscle Weakness,Incontinence Stress,Electricity; Effects,Muscle Weakness Condition
Drug/Device/Intervention: EMG-triggered ES
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Azienda Unità Sanitaria Locale di Piacenza
Location: Fiorenzuola d'Arda, Italy

Timeline & enrollment

Phase: N/A
Start date: May 17, 2024
End date: Jun 15, 2026
Enrollment: 50 participants

Primary outcome

Pelvic Floor Muscles (PFM) Strength

Summary

This research will determine 1) whether the very weak pelvic floor can be improved with surface electromyography (s-EMG)-triggered electrostimulation added to pelvic floor muscle training and 2) whether sEMG-triggered electrostimulation added to pelvic floor muscle training can reduce leakage in Stress Urinary Incontinence (SUI)

ICD-10 classifications

Stress incontinenceNeuromuscular dysfunction of bladder, unspecifiedOther neuromuscular dysfunction of bladderInjury of urinary and pelvic organsNeuromuscular dysfunction of bladder, not elsewhere classified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06419517
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06419517 through Pure Global AI's free database. This phase not specified trial is sponsored by Azienda Unità Sanitaria Locale di Piacenza and is currently Recruiting. The study focuses on Pelvic Floor Muscle Weakness,Incontinence Stress,Electricity; Effects,Muscle Weakness Condition. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.